Your browser is no longer supported. Please, upgrade your browser.
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E35.47 EPS (ttm)3.57 Insider Own0.70% Shs Outstand1.78B Perf Week7.86%
Market Cap224.80B Forward P/E27.25 EPS next Y4.65 Insider Trans-2.63% Shs Float1.76B Perf Month1.13%
Income6.40B PEG2.83 EPS next Q0.94 Inst Own75.40% Short Float0.64% Perf Quarter6.02%
Sales40.23B P/S5.59 EPS this Y24.50% Inst Trans0.04% Short Ratio2.39 Perf Half Y3.38%
Book/sh19.00 P/B6.67 EPS next Y4.49% ROA8.90% Target Price132.28 Perf Year15.75%
Cash/sh5.04 P/C25.13 EPS next 5Y12.53% ROE19.40% 52W Range103.13 - 129.70 Perf YTD15.74%
Dividend1.80 P/FCF39.02 EPS past 5Y7.80% ROI9.70% 52W High-2.30% Beta0.65
Dividend %1.42% Quick Ratio1.40 Sales past 5Y11.10% Gross Margin55.80% 52W Low22.87% ATR2.22
Employees109000 Current Ratio1.80 Sales Q/Q39.50% Oper. Margin18.60% RSI (14)67.76 Volatility1.89% 1.68%
OptionableYes Debt/Eq0.55 EPS Q/Q120.40% Profit Margin15.80% Rel Volume1.22 Prev Close125.05
ShortableYes LT Debt/Eq0.52 EarningsOct 20 BMO Payout45.10% Avg Volume4.68M Price126.72
Recom2.00 SMA206.78% SMA502.88% SMA2006.15% Volume5,715,717 Change1.34%
Oct-14-21Initiated Redburn Neutral
May-25-21Initiated Barclays Overweight $150
Apr-15-21Initiated Atlantic Equities Neutral $122
Jan-28-21Upgrade BTIG Research Neutral → Buy $140
Sep-11-20Initiated Wolfe Research Outperform $124
Jun-01-20Downgrade Goldman Neutral → Sell $84
Mar-05-20Initiated Citigroup Buy $96
Feb-13-20Initiated Goldman Neutral $96
Feb-06-20Resumed BTIG Research Neutral
Jan-02-20Downgrade Guggenheim Buy → Neutral
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Oct-21-21 12:33PM  
05:52AM  
04:58AM  
Oct-20-21 04:56PM  
04:34PM  
04:09PM  
04:01PM  
03:10PM  
02:00PM  
12:20PM  
10:46AM  
10:36AM  
10:35AM  
10:29AM  
10:08AM  
10:01AM  
08:45AM  
08:05AM  
07:44AM  
07:43AM  
07:36AM  
07:30AM  
06:30AM  
05:24AM  
05:09AM  
Oct-19-21 05:30PM  
01:36PM  
10:50AM  
Oct-18-21 11:13AM  
09:22AM  
08:49AM  
07:00AM  
Oct-17-21 06:30AM  
Oct-16-21 08:10AM  
Oct-15-21 11:15AM  
09:35AM  
08:50AM  
Oct-14-21 05:50PM  
05:27PM  
04:18PM  
11:04AM  
09:04AM  
06:11AM  
05:51AM  
Oct-13-21 03:01PM  
11:10AM  
10:44AM  
08:10AM  
Oct-12-21 10:00AM  
09:10AM  
Oct-08-21 05:36AM  
Oct-07-21 05:50PM  
Oct-05-21 02:58PM  
11:16AM  
11:15AM  
11:00AM  
11:00AM  
07:00AM  
Sep-30-21 02:36PM  
09:47AM  
08:00AM  
Sep-28-21 05:50PM  
01:29PM  
09:31AM  
Sep-27-21 02:01PM  
Sep-26-21 06:00AM  
Sep-23-21 09:00AM  
Sep-22-21 05:50PM  
Sep-21-21 05:10PM  
10:55AM  
Sep-20-21 10:54AM  
09:00AM  
08:31AM  
06:12AM  
Sep-17-21 01:51PM  
10:21AM  
Sep-16-21 05:50PM  
10:28AM  
Sep-15-21 12:56PM  
12:46PM  
Sep-14-21 09:58AM  
Sep-13-21 10:55AM  
10:35AM  
09:57AM  
Sep-12-21 05:55AM  
Sep-11-21 06:48AM  
Sep-10-21 07:04PM  
05:50PM  
01:11PM  
09:28AM  
Sep-09-21 01:13PM  
Sep-07-21 12:43PM  
09:13AM  
Sep-03-21 12:16PM  
09:07AM  
Sep-02-21 01:31PM  
09:30AM  
07:00AM  
03:31AM  
Sep-01-21 05:50PM  
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Meniere's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. It has collaboration agreement with Cereno Scientific AB (publ). The company was founded in 1888 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PEDERSON MICHAEL JSENIOR VICE PRESIDENTSep 08Option Exercise50.7223,0081,166,96685,579Sep 10 06:13 PM
PEDERSON MICHAEL JSENIOR VICE PRESIDENTSep 08Sale129.0523,0082,969,17362,571Sep 10 06:13 PM
WOODGRIFT RANDEL WILLIAMSENIOR VICE PRESIDENTSep 03Option Exercise38.401,00038,40050,093Sep 08 05:28 PM
WOODGRIFT RANDEL WILLIAMSENIOR VICE PRESIDENTSep 03Sale129.006,350819,15043,743Sep 08 05:28 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTSep 02Option Exercise42.479,500403,50059,282Sep 03 05:20 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTSep 02Sale127.509,5001,211,25049,782Sep 03 05:20 PM
LANE ANDREW HEXECUTIVE VICE PRESIDENTAug 27Option Exercise38.40135,9255,219,520222,012Aug 31 05:18 PM
LANE ANDREW HEXECUTIVE VICE PRESIDENTAug 27Sale125.47135,92517,055,18986,087Aug 31 05:18 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTAug 17Option Exercise41.0714,500595,50064,282Aug 19 06:27 PM
Karam SammySENIOR VICE PRESIDENTAug 17Option Exercise75.908,000607,20030,926Aug 19 06:29 PM
Karam SammySENIOR VICE PRESIDENTAug 17Sale125.008,0001,000,00022,926Aug 19 06:29 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTAug 17Sale125.0014,5001,812,50049,782Aug 19 06:27 PM
Karam SammySENIOR VICE PRESIDENTAug 03Option Exercise75.908,000607,20030,926Aug 05 05:40 PM
Karam SammySENIOR VICE PRESIDENTAug 03Sale122.508,000980,00022,926Aug 05 05:40 PM
DALE MICHAEL DSENIOR VICE PRESIDENTJul 28Option Exercise50.7217,600892,67257,291Jul 30 05:21 PM
DALE MICHAEL DSENIOR VICE PRESIDENTJul 28Sale120.3317,6002,117,88239,691Jul 30 05:21 PM
Watkin JaredSENIOR VICE PRESIDENTApr 30Option Exercise56.8385,0434,832,629144,826May 04 07:07 PM
Watkin JaredSENIOR VICE PRESIDENTApr 30Sale119.9094,57611,339,73959,783May 04 07:07 PM
Karam SammySENIOR VICE PRESIDENTApr 27Option Exercise75.908,600652,74031,526Apr 29 06:42 PM
BIRD ROGERSENIOR VICE PRESIDENTApr 27Sale122.009,4391,151,55851,083Apr 29 06:38 PM
Karam SammySENIOR VICE PRESIDENTApr 27Sale122.008,6001,049,20022,926Apr 29 06:42 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMar 03Sale121.796,200755,09851,550Mar 05 07:11 PM
WOODGRIFT RANDEL WILLIAMSENIOR VICE PRESIDENTMar 01Sale120.611,034124,71150,461Mar 02 08:11 PM
Watkin JaredSENIOR VICE PRESIDENTMar 01Sale120.611,391167,76969,316Mar 02 08:01 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMar 01Sale120.6158770,79857,750Mar 02 07:59 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTMar 01Sale120.611,664200,695107,430Mar 02 07:54 PM
Ginascol John FEXECUTIVE VICE PRESIDENTMar 01Sale120.6135242,45599,321Mar 02 07:30 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMar 01Sale120.61943113,73582,375Mar 02 07:16 PM
DALE MICHAEL DSENIOR VICE PRESIDENTMar 01Sale120.611,475177,90039,691Mar 02 07:13 PM
BRYNELSEN CHARLESSENIOR VICE PRESIDENTMar 01Sale120.611,002120,85143,550Mar 02 07:02 PM
BIRD ROGERSENIOR VICE PRESIDENTMar 01Sale120.611,113134,23960,522Mar 02 06:55 PM
Ahlberg Gregory ASENIOR VICE PRESIDENTMar 01Sale120.611,052126,88214,045Mar 02 06:49 PM
Kumbier MichelleDirectorFeb 23Buy122.502,040249,9007,296Feb 25 06:05 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTFeb 22Sale121.8340048,73475,706Feb 23 07:05 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTFeb 16Sale128.4950564,88763,373Feb 18 05:57 PM
Funck Robert EEXECUTIVE VICE PRESIDENTFeb 02Option Exercise39.1231,3251,225,434193,542Feb 04 06:56 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 02Sale123.033,130385,08459,681Feb 03 07:20 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTFeb 01Option Exercise38.78203,3937,887,902355,289Feb 03 07:10 PM
Scoggins Christopher JSENIOR VICE PRESIDENTFeb 01Option Exercise44.8345,0002,017,20084,706Feb 03 07:14 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 01Option Exercise38.4018,750720,00081,561Feb 03 07:20 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 01Sale122.7918,7502,302,26462,811Feb 03 07:20 PM
Scoggins Christopher JSENIOR VICE PRESIDENTFeb 01Sale123.2445,0005,545,80039,706Feb 03 07:14 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTFeb 01Sale123.47203,39325,113,252151,896Feb 03 07:10 PM
NOVAKOVIC PHEBE NDirectorDec 04Option Exercise34.9714,681513,43145,794Dec 08 05:58 PM
NOVAKOVIC PHEBE NDirectorDec 04Sale107.284,790513,84941,004Dec 08 05:58 PM
OSBORN WILLIAM ADirectorNov 24Option Exercise43.6421,448935,99179,745Nov 25 05:41 PM
Funck Robert EExecutive Vice President & CFOOct 26Option Exercise38.4083,3333,199,987265,550Oct 28 06:33 PM
Funck Robert EExecutive Vice President & CFOOct 26Sale108.8383,3339,068,955182,217Oct 28 06:33 PM